Location · Minneapolis, MN
Clinical trials in Minneapolis, MN
278 recruiting studies have a site in the Minneapolis area, and 96 of them accept healthy volunteers. The area includes Saint Paul, St. Paul, Bloomington, Edina, Plymouth, Maplewood and nearby cities.
278 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
More recruiting studies (pay not posted)
- RecruitingPhase 2
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
Corxel Pharmaceuticals
- Location
- Birmingham, AL + 32 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2/Phase 3
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
DiaMedica Therapeutics Inc
- Location
- Fairhope, AL + 35 other US sites
- Eligibility basics
- Ages 18–90
- RecruitingPhase 3
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
AbbVie
- Location
- Huntsville, AL + 87 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.
Basilea Pharmaceutica
- Location
- Birmingham, AL + 18 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)
Vega Therapeutics, Inc
- Location
- Little Rock, AR + 13 other US sites
- Eligibility basics
- Ages 12–75
- Recruiting
Cephea Early Feasibility Study
Abbott Medical Devices
- Location
- Phoenix, AZ + 19 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
COUR Pharmaceutical Development Company, Inc.
- Location
- Tucson, AZ + 44 other US sites
- Eligibility basics
- Ages 12–35
- RecruitingPhase 2
Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.
XyloCor Therapeutics, Inc.
- Location
- Birmingham, AL + 12 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)
Cardiol Therapeutics Inc.
- Location
- Phoenix, AZ + 20 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)
Takeda
- Location
- Birmingham, AL + 9 other US sites
- Eligibility basics
- Up to age 17
- Recruiting
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
BrioHealth Solutions, Inc.
- Location
- Birmingham, AL + 46 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingPhase 3
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
AstraZeneca
- Location
- Minneapolis, MN + 2 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Eli Lilly and Company
- Location
- Birmingham, AL + 28 other US sites
- Eligibility basics
- Ages 6–17
- Recruiting
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
SetPoint Medical Corporation
- Location
- Irvine, CA + 8 other US sites
- Eligibility basics
- Ages 22–60
- Recruiting
Chronic Evaluation of Novel Pacemaker System
Calyan Technologies
- Location
- Minneapolis, MN
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
AbbVie
- Location
- Little Rock, AR + 11 other US sites
- Eligibility basics
- Ages 5–17
- Recruiting
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
Kaneka Medical America LLC
- Location
- Loma Linda, CA + 9 other US sites
- Eligibility basics
- Up to age 21
- RecruitingPhase 2
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
R1 Therapeutics
- Location
- Huntsville, AL + 23 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Sanofi Pasteur, a Sanofi Company
- Location
- Scottsdale, AZ + 78 other US sites
- Eligibility basics
- Ages 18–45
- Recruiting
Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia
SPIRE Therapeutics Inc.
- Location
- Ann Arbor, MI + 7 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Kallyope Inc.
- Location
- Birmingham, AL + 111 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1/Phase 2
AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)
NGGT INC.
- Location
- Orange, CA + 4 other US sites
- Eligibility basics
- Ages 18–55
- Recruiting
VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)
VDyne, Inc.
- Location
- Minneapolis, MN
- Eligibility basics
- Ages 18+
- Recruiting
Alleviant ALLAY-HF Study
Alleviant Medical, Inc.
- Location
- Tucson, AZ + 42 other US sites
- Eligibility basics
- Ages 40+